Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 38.55 NZD 4.3% Market Closed
Market Cap: 22.6B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Fisher & Paykel Healthcare Corporation Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fisher & Paykel Healthcare Corporation Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Total Liabilities & Equity
NZ$2.3B
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Truscreen Group Ltd
NZX:TRU
Total Liabilities & Equity
NZ$4m
CAGR 3-Years
-30%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
No Stocks Found

Fisher & Paykel Healthcare Corporation Ltd
Glance View

Market Cap
22.5B NZD
Industry
Health Care

Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products, such as its award-winning humidifiers and nasal mask systems, designed to support patients with respiratory issues and obstructive sleep apnea. The company boasts a diverse international presence, with a robust distribution network that allows it to serve healthcare professionals and patients in over 120 countries. For investors, Fisher & Paykel stands out not only for its continual focus on innovation but also for its stable financial performance. Throughout its history, the company has demonstrated resilience and adaptability, adeptly navigating market fluctuations and healthcare trends. With a strong balance sheet, a consistent track record of revenue growth, and a commitment to shareholder returns, Fisher & Paykel is well-positioned for future expansion, particularly as global healthcare demands rise. As the aging population and the increasing prevalence of chronic respiratory conditions drive market growth, investors may find Fisher & Paykel Healthcare a compelling opportunity, with its blend of innovative solutions and solid financial foundations paving the way for sustained success.

FPH Intrinsic Value
23.16 NZD
Overvaluation 40%
Intrinsic Value
Price

See Also

What is Fisher & Paykel Healthcare Corporation Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
2.3B NZD

Based on the financial report for Mar 31, 2024, Fisher & Paykel Healthcare Corporation Ltd's Total Liabilities & Equity amounts to 2.3B NZD.

What is Fisher & Paykel Healthcare Corporation Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
14%

Over the last year, the Total Liabilities & Equity growth was 4%. The average annual Total Liabilities & Equity growth rates for Fisher & Paykel Healthcare Corporation Ltd have been 3% over the past three years , 14% over the past five years .

Back to Top